华熙生物预计2025年净利2.7亿元到3.2亿元，同比增加54.93%到83.63%

Core Viewpoint - Huaxi Biological (688363) expects a significant increase in net profit for 2025, projecting a range of 270 million to 320 million yuan, representing a year-on-year growth of 54.93% to 83.63% [1] Group 1: Financial Performance - The company anticipates a net profit of 270 million to 320 million yuan for 2025, indicating a substantial increase compared to the previous year [1] - The projected growth is attributed to systematic optimization of organizational structure, functional integration, and upgraded operational models [1] Group 2: Operational Efficiency - The company is transitioning from "scale expansion" to "quality growth," aiming to enhance operational efficiency and optimize costs [1] - Management expenses are expected to decrease by over 10% year-on-year in 2025, providing foundational support for profit growth [1] Group 3: Business Strategy - The company focuses on professional development and continues to optimize its business structure and resource allocation [1] - Sales expenses are projected to decline by over 30% year-on-year, contributing to sustained improvement in profitability despite revenue pressures [1]